ArticleThoracic cancer2016

RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.

De-Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.